カテゴリ： MarketLine, ロシア, 企業調査

Magnitogorsk Metallurgicheskiy Kombinat：企業の戦略・SWOT・財務情報

◆英語タイトル：Magnitogorsk Metallurgicheskiy Kombinat - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C13929
◆発行会社（調査会社）：MarketLine
◆発行日：2019年2月
◆ページ数：36
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ロシア
◆産業分野：金属・鉱業
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Magnitogorsk Metallurgicheskiy Kombinat – Strategy, SWOT and Corporate Finance Report
Summary

Magnitogorsk Metallurgicheskiy Kombinat – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Magnitogorsk Metallurgicheskiy Kombinat (MMK) is steel and steel related products manufacturer. The company’s product portfolio includes iron ore, sinter ore, long and coated flat products, wires, baling strips, and railway and mechanical fasteners. It also produces hot-rolled and cold-rolled steel products such as pickled sheet, black tin, galvanized sheets, moulded section and coils. In addition, the company undertakes mining and refining of coal, production and processing of coking coal, and collection and processing of scrap activities. Its products find application in various industries such as shipbuilding, railroad machinery, construction, automotive manufacturing, oil and gas, and pipe production. MMK is headquartered in Magnitogorsk, Chelyabinsk Oblast, Russia.

Scope

- Detailed information on Magnitogorsk Metallurgicheskiy Kombinat required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Magnitogorsk Metallurgicheskiy Kombinat in the form of a SWOT analysis
- An in-depth view of the business model of Magnitogorsk Metallurgicheskiy Kombinat including a breakdown and examination of key business segments
- Intelligence on Magnitogorsk Metallurgicheskiy Kombinat’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Magnitogorsk Metallurgicheskiy Kombinat, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Magnitogorsk Metallurgicheskiy Kombinat and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Magnitogorsk Metallurgicheskiy Kombinat as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Magnitogorsk Metallurgicheskiy Kombinat’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Magnitogorsk Metallurgicheskiy Kombinat: Company Overview
Magnitogorsk Metallurgicheskiy Kombinat: Overview and Key Facts
Magnitogorsk Metallurgicheskiy Kombinat: Overview
Magnitogorsk Metallurgicheskiy Kombinat: Key Facts
Magnitogorsk Metallurgicheskiy Kombinat: Key Employees
Magnitogorsk Metallurgicheskiy Kombinat: Key Employee Biographies
Magnitogorsk Metallurgicheskiy Kombinat: Major Products and Services
Magnitogorsk Metallurgicheskiy Kombinat: Company History
Magnitogorsk Metallurgicheskiy Kombinat: Management Statement
Magnitogorsk Metallurgicheskiy Kombinat: Locations and Subsidiaries
Magnitogorsk Metallurgicheskiy Kombinat: Key Competitors
Magnitogorsk Metallurgicheskiy Kombinat: Company Analysis
Magnitogorsk Metallurgicheskiy Kombinat: Business Description
Magnitogorsk Metallurgicheskiy Kombinat: SWOT Analysis
Magnitogorsk Metallurgicheskiy Kombinat: SWOT Overview
Magnitogorsk Metallurgicheskiy Kombinat: Strengths
Magnitogorsk Metallurgicheskiy Kombinat: Weaknesses
Magnitogorsk Metallurgicheskiy Kombinat: Opportunities
Magnitogorsk Metallurgicheskiy Kombinat: Threats
Magnitogorsk Metallurgicheskiy Kombinat: Corporate Financial Deals Activity
Magnitogorsk Metallurgicheskiy Kombinat: Financial Deals Overview
Magnitogorsk Metallurgicheskiy Kombinat: Top Deals 2015 – 2019YTD*
Magnitogorsk Metallurgicheskiy Kombinat: Capital Raising
Magnitogorsk Metallurgicheskiy Kombinat: Recent Developments
Magnitogorsk Metallurgicheskiy Kombinat: News and Events Summary
Magnitogorsk Metallurgicheskiy Kombinat: Business Expansion
Magnitogorsk Metallurgicheskiy Kombinat: Financial Performance
Magnitogorsk Metallurgicheskiy Kombinat: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Magnitogorsk Metallurgicheskiy Kombinat: Key Facts
Table 2: Magnitogorsk Metallurgicheskiy Kombinat: Key Employees
Table 3: Magnitogorsk Metallurgicheskiy Kombinat: Company History
Table 4: Magnitogorsk Metallurgicheskiy Kombinat: Locations and Subsidiaries
Table 5: Magnitogorsk Metallurgicheskiy Kombinat: Key Competitors
Table 6: Magnitogorsk Metallurgicheskiy Kombinat: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: Magnitogorsk Metallurgicheskiy Kombinat: Top Deals 2015 - 2019YTD*
Table 8: Magnitogorsk Metallurgicheskiy Kombinat: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 9: Magnitogorsk Metallurgicheskiy Kombinat: Capital Raising by Deal Type (2015 - YTD*2019)
Table 10: Magnitogorsk Metallurgicheskiy Kombinat: News and Events Summary
Table 11: Magnitogorsk Metallurgicheskiy Kombinat: Business Expansion
Table 12: Magnitogorsk Metallurgicheskiy Kombinat: Financial Performance
Table 13: Magnitogorsk Metallurgicheskiy Kombinat: Strategy and Operations

List of Figures
Figure 1: Magnitogorsk Metallurgicheskiy Kombinat: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 2: Magnitogorsk Metallurgicheskiy Kombinat: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Figure 3: Magnitogorsk Metallurgicheskiy Kombinat: Capital Raising by Deal Type (2015 - YTD*2019)

★海外企業調査レポート[Magnitogorsk Metallurgicheskiy Kombinat：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Riyad Bank：企業の戦略・SWOT・財務情報
    Riyad Bank - Strategy, SWOT and Corporate Finance Report Summary Riyad Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Damco International A/S：戦略・SWOT・企業財務分析
    Damco International A/S - Strategy, SWOT and Corporate Finance Report Summary Damco International A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ultimovacs AS-製薬・医療分野：企業M&A・提携分析
    Summary Ultimovacs AS (Ultimovacs) is a provider of novel immunotherapies for cancer treatment. The company develops synthetic peptide based therapeutic vaccines that can be used on its own and also in combination with conventional therapies such as surgery, chemotherapy, and irradiation. Its UV1 is …
  • Humanwell Healthcare (Group) Co Ltd (600079)：製薬・医療：M&Aディール及び事業提携情報
    Summary Humanwell Healthcare (Group) Co Ltd (Humanwell), formerly Wuhan Humanwell Hi-Tech Industry Co Ltd is a pharmaceutical company that offers generic products. The company offers pharmaceutical, medical instrument and reproductive health care products and technologies. Its products include anest …
  • Genocea Biosciences Inc (GNCA)：企業の財務・戦略的SWOT分析
    Summary Genocea Biosciences Inc (Genocea), formerly Genocea Inc, is a cancer vaccines provider. The company discovers and develops T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. It provides Gen-009 and Gen-010 neoantigen cancer Vaccine pipeline.Genoceaatlas tec …
  • Genome Institute of Singapore-製薬・医療分野：企業M&A・提携分析
    Summary Genome Institute of Singapore (GIS) is a research institute that provides various research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It handles the latest in technology and comprises early ca …
  • ConceptoMed AS-医療機器分野：企業M&A・提携分析
    Summary ConceptoMed AS (ConceptoMed) is a medical device manufacturer that offers medtech products. The company's products comprise medical syringe and needle, medical tools, Luer-Jack, ConceptoShield, and disposable medical instruments and devices. ConceptoMed also offers epidural injections, plexu …
  • US WorldMeds LLC：製薬・医療：M&Aディール及び事業提携情報
    Summary US WorldMeds LLC (US WorldMeds) is a specialty pharmaceutical company that develops, licenses and markets healthcare products to improve lives of patients with challenging conditions and unmet medical needs. The company’s products comprise apokyn, myobloc and revonto. Its apokyn is used for …
  • Parker Institute for Cancer Immunotherapy：製薬・医療：M&Aディール及び事業提携情報
    Summary Parker Institute for Cancer Immunotherapy (Parker Institute), a subsidiary of The Parker Foundation is a nonprofit public benefit corporation which focuses on the development of immune therapies for the treatment of cancer. The institute coordinates together the scientists, nonprofits, acade …
  • Banco Bradesco SA：企業の戦略・SWOT・財務情報
    Banco Bradesco SA - Strategy, SWOT and Corporate Finance Report Summary Banco Bradesco SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Vaxil Bio Ltd (VXL)：製薬・医療：M&Aディール及び事業提携情報
    Summary Vaxil Bio Ltd (Vaxil Bio), formerly Emerge Resources Corp, is a drug development company that develops immunotherapy platform. The company’s immunptherapy pipeline products include antigen specific immunotherapies, signal peptide specific antibodies and anti-infectives. It develops Vaxhit te …
  • MADO Ice Cream & Foodstuffs Co., Ltd.：企業の戦略・SWOT・財務分析
    MADO Ice Cream & Foodstuffs Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary MADO Ice Cream & Foodstuffs Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Western Gas Equity Partners LP：企業の戦略・SWOT・財務情報
    Western Gas Equity Partners LP - Strategy, SWOT and Corporate Finance Report Summary Western Gas Equity Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • RPC Group PLC：企業の戦略・SWOT・財務情報
    RPC Group PLC - Strategy, SWOT and Corporate Finance Report Summary RPC Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • IKM Gruppen AS：石油・ガス：M&Aディール及び事業提携情報
    Summary IKM Gruppen AS (IKM Gruppen) is an oil and gas company. The company operates through its business divisions such as subsea completion and commissioning, electrical instrument and automation, engineering and operations, fabrication and inspection, and rig and downhole services. Its subsea com …
  • Pharco Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Pharco Pharmaceuticals Inc (Pharco Pharmaceuticals), a subsidiary of Pharco Corp, is a manufacturer of branded and generic pharmaceutical products. The company offers products such as alambupine, alfatral, amlodipine, amrase, amrizole, bisadyl, bromhexine, carbolase, ciprofloxacin, dexametha …
  • Novacyt SA (ALNOV)：医療機器：M&Aディール及び事業提携情報
    Summary Novacyt SA (Novacyt) is a medical device company that develops and markets medical cytology solutions. The company offers oncology and infectious disease diagnostic products. It also sells diagnostic reagents used in LBC, oncology, microbiology, haematology and serology testing. Novacyt deve …
  • Nektar Therapeutics (NKTR)：企業の財務・戦略的SWOT分析
    Nektar Therapeutics (NKTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Symic Biomedical Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Symic Biomedical Inc (Symic Biomedical) is a biopharmaceutical company that develops new therapeutics focused on matrix biology. The company’s pipeline products include SB-030 and SB-061. Its SB-030 is a clinical candidate used for the prevention of peripheral vascular diseases or vein graft …
  • ActiveCare Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary ActiveCare Inc (ActiveCare) is a medical equipment company that monitors health analytics. The company provides monitoring component to traditional disease management and wellness solutions. It offers solutions such as diabetes supplies, online web-based administrative tools, browser and iPh …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆